ATE408626T1 - Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen - Google Patents

Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen

Info

Publication number
ATE408626T1
ATE408626T1 AT01949734T AT01949734T ATE408626T1 AT E408626 T1 ATE408626 T1 AT E408626T1 AT 01949734 T AT01949734 T AT 01949734T AT 01949734 T AT01949734 T AT 01949734T AT E408626 T1 ATE408626 T1 AT E408626T1
Authority
AT
Austria
Prior art keywords
diagnostics
peptides
cardiovascular diseases
cyclised
affinity
Prior art date
Application number
AT01949734T
Other languages
German (de)
English (en)
Inventor
Outi Narvanen
Seppo Yla-Herttuala
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Application granted granted Critical
Publication of ATE408626T1 publication Critical patent/ATE408626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01949734T 2000-07-18 2001-07-18 Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen ATE408626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use

Publications (1)

Publication Number Publication Date
ATE408626T1 true ATE408626T1 (de) 2008-10-15

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949734T ATE408626T1 (de) 2000-07-18 2001-07-18 Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen

Country Status (12)

Country Link
US (2) US20040091934A1 (https=)
EP (1) EP1301537B1 (https=)
JP (1) JP2004504327A (https=)
AT (1) ATE408626T1 (https=)
AU (1) AU2001270851A1 (https=)
CA (1) CA2417789A1 (https=)
DE (1) DE60135846D1 (https=)
DK (1) DK1301537T3 (https=)
ES (1) ES2312455T3 (https=)
GB (1) GB0017641D0 (https=)
PT (1) PT1301537E (https=)
WO (1) WO2002006314A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
AU2002362612B2 (en) 2001-09-28 2007-11-15 Cedars-Sinai Medical Center Prevention and treatment of restenosis by local administration of drug
JP2007531537A (ja) 2004-04-06 2007-11-08 セダーズ−シナイ　メディカル　センター アポリポタンパク質ａ−ｉおよびアポリポタンパク質ａ−ｉｍｉｌａｎｏをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
WO2008080030A2 (en) * 2006-12-22 2008-07-03 Abbott Laboratories Cardiovascular autoimmune disease panel and methods of using same
MX2009004460A (es) * 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
RU2013126628A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
CA2817543A1 (en) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
EP3463416A1 (en) 2016-05-31 2019-04-10 CardioVax, LLC Methods for diagnosing and treating systemic lupus erythematosus
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
WO1998059248A1 (en) * 1997-06-20 1998-12-30 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Also Published As

Publication number Publication date
ES2312455T3 (es) 2009-03-01
GB0017641D0 (en) 2000-09-06
AU2001270851A1 (en) 2002-01-30
DK1301537T3 (da) 2008-12-08
PT1301537E (pt) 2008-12-04
WO2002006314A3 (en) 2002-04-18
EP1301537B1 (en) 2008-09-17
CA2417789A1 (en) 2002-01-24
DE60135846D1 (de) 2008-10-30
EP1301537A2 (en) 2003-04-16
US20040091934A1 (en) 2004-05-13
US20080261234A1 (en) 2008-10-23
JP2004504327A (ja) 2004-02-12
WO2002006314A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
ATE408626T1 (de) Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen
DE60323231D1 (de) Verkürzte tau proteine
ATE278186T1 (de) Elektrochemischer sensor zur bestimmung der blutgerinnung, ein entsprechendes blutgerinnungsmesssystem sowie ein verfahren zur bestimmung der blutgerinnung
ATE526399T1 (de) Neue biologische einheiten und deren verwendung
EP1565482A4 (en) A34 AND A33 LIKE-3 DNA, PROTEINS, ANTIBODIES, AND TREATMENT METHODS USED THEREOF
ATE402188T1 (de) Bindungsproteine als biosensoren
DE60326259D1 (de) Neue fructosylpeptidoxidase und deren nutzung
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DE59207351D1 (de) Verbesserte Aktivierung von rekombinanten Proteinen
NO20012017D0 (no) Anvendelse av VEGF-C eller VEGF-D gen eller protein for å forebygge restenose
DE60109839D1 (de) Ausgleich der Abnutzung von Spitzen und Fersen
DE60313659D1 (de) Borrelidin-derivate und ihre medizinische anwendung
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
SE8801701D0 (sv) Production technology based on enzymic method
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
DK1257829T3 (da) Komplementationsassay der vurderer proteinoplöselighed og -foldning
DE69831229D1 (de) Schnelle bestimmung des verhältnisses von biologischen molekülen
ATE324446T1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
ATE333513T1 (de) Verfahren und zusammensetzungen zur überwachung der modifikation von natürlichen bindungspartners
WO2002102847A1 (fr) Nouveau ligand et son adn
DE60129220D1 (de) Detektion und charakterisierung der aktivität von proteinen, welche an der reparatur von dna-läsionen beteiligt sind
ATE389029T1 (de) Protease assay zur kontrolle medikamentöser therapie
BR0308978A (pt) fragmentos de peptìdeos sintéticos ativos
ATE309193T1 (de) Mischungen von halbestern mehrbasiger organischer säuren und langkettiger alkanole,ihre herstellung und verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1301537

Country of ref document: EP

REN Ceased due to non-payment of the annual fee